GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 208 filers reported holding GENMAB A/S in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q2 2023 | $86 | -4.4% | 2,254 | -5.3% | 0.00% | 0.0% |
Q1 2023 | $90 | -28.6% | 2,381 | -19.7% | 0.00% | 0.0% |
Q4 2022 | $126 | -99.9% | 2,966 | -22.8% | 0.00% | 0.0% |
Q3 2022 | $123,000 | -10.2% | 3,843 | -8.9% | 0.00% | 0.0% |
Q2 2022 | $137,000 | -22.6% | 4,219 | -13.8% | 0.00% | 0.0% |
Q1 2022 | $177,000 | -14.5% | 4,897 | -6.6% | 0.00% | 0.0% |
Q4 2021 | $207,000 | +84.8% | 5,241 | +70.8% | 0.00% | 0.0% |
Q3 2021 | $112,000 | -39.1% | 3,068 | -32.0% | 0.00% | 0.0% |
Q2 2021 | $184,000 | +25.2% | 4,512 | +24.7% | 0.00% | 0.0% |
Q1 2021 | $147,000 | 0.0% | 3,617 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $147,000 | +31.2% | 3,617 | +17.9% | 0.00% | 0.0% |
Q3 2020 | $112,000 | +20.4% | 3,068 | +11.8% | 0.00% | 0.0% |
Q2 2020 | $93,000 | +78.8% | 2,744 | +10.8% | 0.00% | – |
Q1 2020 | $52,000 | -7.1% | 2,476 | -0.4% | 0.00% | – |
Q4 2019 | $56,000 | +86.7% | 2,486 | +67.1% | 0.00% | – |
Q3 2019 | $30,000 | – | 1,488 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |